Kowa Pharmaceutical Europe Co. Ltd.
Kowa Pharmaceutical Europe Co. Ltd. is a specialty pharmaceutical company located in the UK and is a division of Kowa Company, Ltd., a multinational Japanese company actively engaged in a broad variety of manufacturing and trading activities. Kowa are committed to ground-breaking research, development and marketing, seeking to ensure quality products are made available to people within Europe and beyond, to contribute to a better standard of health and a more comfortable life for all. Find out more.
2nd – 6th April 2014
World Ophthalmology Congress (WOC) Booth E-21 – New data presented on Rho kinase inhibitor K-115 in the treatment of primary open-angle glaucoma and ocular hypertension
31st May – 3rd June 2014
82nd European Atherosclerosis Society (EAS) Congress – Spanish experts offer guidance on the use of statins in people at risk of developing diabetes mellitus
13th – 17th September 2014
Kowa are attending the European Society of Cataract and Refractive Surgeons (ESCRS) Congress – come and visit us at our booth B03
25th – 28th September 2014
Kowa are attending Deutsche Ophthalmologische Gesellschaft (DOG) – come and visit us at our booth B.06
“Kowa is committed to the healthcare global community.”
Our entrepreneurial initiative means we’re determined to meet future needs.